Therapeutic effect of gefitinib on patients with advanced EGFR-mutation NSCLC

original articles

Ailing Xu, Haixia Yan, Tongliang Bu

Vol. 34

Issue 1

Pages 481-486

Published 01 Jan 2021

Authors & Affiliations

Ailing Xu

,

Haixia Yan

,

Tongliang Bu

This study aims to study the role of gefitinib on patients with advanced EGFR-mutation NSCLC

NSCLC

EGFR

gefitinib

MMP-9

CYFRA21-1

immune function

PlumX Metrics